- Home
- JFU vs DXR Comparison
JFU vs DXR Comparison
Compare JFU & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFU
- DXR
- Stock Information
- Founded
- JFU 2006
- DXR 1970
- Country
- JFU China
- DXR United States
- Employees
- JFU N/A
- DXR N/A
- Industry
- JFU Finance: Consumer Services
- DXR Medical/Dental Instruments
- Sector
- JFU Finance
- DXR Health Care
- Exchange
- JFU Nasdaq
- DXR Nasdaq
- Market Cap
- JFU 58.2M
- DXR 46.9M
- IPO Year
- JFU 2019
- DXR N/A
- Fundamental
- Price
- JFU $4.55
- DXR $12.94
- Analyst Decision
- JFU
- DXR Strong Buy
- Analyst Count
- JFU 0
- DXR 1
- Target Price
- JFU N/A
- DXR $25.00
- AVG Volume (30 Days)
- JFU 7.5K
- DXR 5.7K
- Earning Date
- JFU 12-09-2022
- DXR 01-01-0001
- Dividend Yield
- JFU N/A
- DXR N/A
- EPS Growth
- JFU 3110.57
- DXR 3.46
- EPS
- JFU 3.04
- DXR 0.36
- Revenue
- JFU $44,573,690.00
- DXR $66,306.00
- Revenue This Year
- JFU N/A
- DXR N/A
- Revenue Next Year
- JFU N/A
- DXR N/A
- P/E Ratio
- JFU $1.48
- DXR $35.89
- Revenue Growth
- JFU 8.19
- DXR N/A
- 52 Week Low
- JFU $1.01
- DXR $6.55
- 52 Week High
- JFU $5.88
- DXR $14.00
- Technical
- Relative Strength Index (RSI)
- JFU 50.98
- DXR 50.55
- Support Level
- JFU $4.45
- DXR $12.52
- Resistance Level
- JFU $4.82
- DXR $13.13
- Average True Range (ATR)
- JFU 0.26
- DXR 0.61
- MACD
- JFU -0.12
- DXR -0.08
- Stochastic Oscillator
- JFU 17.46
- DXR 71.74
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.